GlobalData’s latest report reveals that Iran’s clinical trials have been affected, with 348 trials initiated in Q2, compared to India, with 944

Baxdrostat is a potential first-in-class, highly selective aldosterone synthase inhibitor that targets the hormone driving elevated blood pressure and increased cardiovascular and renal risk

Ibrutinib tablets had annual sales of $ 2148.9 mn in the United States (IQVIA MAT May 2025)

The issue is expected to raise ₹4,992.51 lakh, which will be utilised to strengthen the company’s balance sheet, support growth initiatives

Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India

The facility, located in Verna Industrial Estate, manufactures sterile drug products

Adcock Ingram generated revenue of R9.6 billion ($ 536 million*) in the financial year June’24 and delivered a gross margin of 33.4 per cent

Production Linked Incentive Scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs

The PRIP scheme has been launched with an outlay of ₹ 5,000 crore to transform India’s Pharma MedTech sector

Seema Ahuja will post her retirement from Biocon Biologics move into a non-business facing role in Biocon Chairperson’s office

Milind Sathe, Vice President -IP and Tech, Themis Medicare, explains how certain robust search and tracking facilities can enhance the efficiency at the Indian Patent Office, thereby inspiring...